Taken together, our study demonstrated that ACC1 deletion in T cells has strong anti-inflammatory effects in IMQ-induced psoriasis, suggesting that pharmacological inhibition of FAS could provide novel therapeutic avenues for psoriasis therapy. Here, FAS is linked to psoriasis.